Expression and clinical significance of CD74 and MMP-9 in colon adenocarcinomas

被引:2
作者
Ruan, Peng [1 ]
Gu, Yangchun [2 ]
Zhou, Huijun [3 ]
Zhang, Wen [4 ]
Wang, Dingxue [5 ]
Liang, Jinglin [6 ]
Li, Cong [7 ]
机构
[1] Wuhan Univ, Dept Oncol, Renmin Hosp, Wuhan 430060, Hubei, Peoples R China
[2] Peking Univ, Dept Med Oncol & Radiat Sickness, Hosp 3, Beijing 100191, Peoples R China
[3] Hunan Canc Hosp, Dept Digest & Urol, Changsha 430013, Peoples R China
[4] Kunming Med Univ, Yunnan Tumor Hosp, Dept Abdominal Surg, Affiliated Hosp 3, Kunming 671000, Yunnan, Peoples R China
[5] Guiyang Coll Tradit, Dept Oncol, Affiliated Hosp 1, Guiyang 550002, Peoples R China
[6] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Colorectal Surg, 26 Erheng Rd, Guangzhou 510655, Peoples R China
[7] Sun Yat Sen Univ, Dept Colorectal Surg, State Key Lab Oncol South China, Canc Ctr,Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Peoples R China
来源
JOURNAL OF BUON | 2020年 / 25卷 / 02期
关键词
colon adenocarcinoma; CD74; MMP-9; clinicopathological characteristics; prognosis; CANCER; SURVIVAL;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To detect the expressions of CD74 and matrix metalloproteinase-9 (MMP-9) in colon adenocarcinomas, and to explore the relationship between the expressions and clinicopathological characteristics and prognosis. Methods: 98 cases of colon adenocarcinoma tissues from patients who underwent colon cancer resection in the Sixth Affiliated Hospital, Sun Yat-sen University from January 2013 to March 2015 comprised the experimental group, while 71 cases of colon mucosa tissues from patients who underwent colon polypectomy during the same period comprised the control group. qRT-PCR was used to detect the expressions of CD44 and MMP-9 mRNAs in the two groups, in order to analyze their correlation in colon adenocarcinomas, and to also analyze their relationship with clinicopathological characteristics and prognosis. Results: The expressions of CD74 and MMP-9 mRNAs in colon adenocarcinoma tissues were significantly higher than those in normal colon mucosa tissues (p<0.05). The expressions of CD74 and MMP-9 mRNAs had no significant relationship with the patient's gender, age, differentiation grade and tumor type in colon adenocarcinoma tissues (p>0.05), but had significant correlation with lymph node metastasis and pathological stage (p<0.05). According to the average expressions of CD74 and MMP-9 mRNAs, the patients were divided into low and high expression groups. The 3-year survival rate of patients in the low expression group was significantly higher than that in the high expression group (p<0.05). Moreover, the expressions of CD74 and MMP-9 were positively correlated (r = 0.853, p<0.001). Conclusion: CD74 and MMP-9 are highly expressed in colon adenocarcinomas, and their expressions are closely related to the pathological stage, lymph node metastasis and prognosis of colon adenocarcinoma patients. Therefore, they can be used as important biological markers for diagnosis and prognosis prediction of colon adenocarcinoma.
引用
收藏
页码:927 / 932
页数:6
相关论文
共 21 条
[1]   Tetrac-conjugated polymersomes for integrin-targeted delivery of camptothecin to colon adenocarcinoma in vitro and in vivo [J].
Alibolandi, Mona ;
Rezvani, Rouhollah ;
Farzad, Sara Amel ;
Taghdisi, Seyed Mohammad ;
Abnous, Khalil ;
Ramezani, Mohammad .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 532 (01) :581-594
[2]   FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death [J].
Alinari, Lapo ;
Mahoney, Emilia ;
Patton, John ;
Zhang, Xiaoli ;
Lenguyen Huynh ;
Earl, Christian T. ;
Mani, Rajeswaran ;
Mao, Yicheng ;
Yu, Bo ;
Quinion, Carl ;
Towns, William H. ;
Chen, Ching-Shih ;
Goldenberg, David M. ;
Blum, Kristie A. ;
Byrd, John C. ;
Muthusamy, Natarajan ;
Praetorius-Ibba, Mette ;
Baiocchi, Robert A. .
BLOOD, 2011, 118 (26) :6893-6903
[3]   CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease [J].
Borghese, Federica ;
Clanchy, Felix I. L. .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (03) :237-251
[4]   CD74 is expressed by multiple myeloma and is a promising target for therapy [J].
Burton, JD ;
Ely, S ;
Reddy, PK ;
Stein, R ;
Gold, DV ;
Cardillo, TM ;
Goldenberg, DM .
CLINICAL CANCER RESEARCH, 2004, 10 (19) :6606-6611
[5]  
Candido S, 2015, BIOCHIM BIOPHYS ACTA, V1863, P438
[6]   Expression of Macrophage Migration Inhibitory Factor and CD74 in Cervical Squamous Cell Carcinoma [J].
Cheng, Rong-jie ;
Deng, Wei-guo ;
Niu, Chun-bo ;
Li, Yi-yang ;
Fu, Yan .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (06) :1004-1012
[7]   CD74 expression is increased in high-grade, invasive urothelial carcinoma of the bladder [J].
Choi, Jung-Woo ;
Kim, Younghye ;
Lee, Ju-Han ;
Kim, Young-Sik .
INTERNATIONAL JOURNAL OF UROLOGY, 2013, 20 (02) :251-255
[8]   The effectiveness of cyclooxygenase-2 inhibitors and evaluation of angiogenesis in the model of experimental colorectal cancer [J].
Gungor, Hilal ;
Ilhan, Nevin ;
Eroksuz, Hatice .
BIOMEDICINE & PHARMACOTHERAPY, 2018, 102 :221-229
[9]   A novel cancer testis antigen target A-kinase anchor protein (AKAP4) for the early diagnosis and immunotherapy of colon cancer [J].
Jagadish, Nirmala ;
Parashar, Deepak ;
Gupta, Namita ;
Agarwal, Sumit ;
Sharma, Aditi ;
Fatima, Rukhsar ;
Suri, Vaishali ;
Kumar, Rajive ;
Gupta, Anju ;
Lohiya, Nirmal Kumar ;
Suri, Anil .
ONCOIMMUNOLOGY, 2016, 5 (02)
[10]   Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal carcinoma [J].
Logani, S ;
Oliva, E ;
Arnell, PM ;
Amin, MB ;
Young, RH .
MODERN PATHOLOGY, 2005, 18 (01) :19-25